HTDS (Hard to Treat Diseases) Gross-Profit-to-Asset % : 0.00% (As of . 20)

View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Hard to Treat Diseases's annualized Gross Profit for the quarter that ended in . 20 was $ Mil. Hard to Treat Diseases's average Total Assets over the quarter that ended in . 20 was $ 0 Mil. Therefore, Hard to Treat Diseases's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.

Hard to Treat Diseases Gross-Profit-to-Asset % Historical Data

The historical data trend for Hard to Treat Diseases's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Gross-Profit-to-Asset % Chart

Hard to Treat Diseases Annual Data

Trend

Gross-Profit-to-Asset %

Hard to Treat Diseases Quarterly Data

Gross-Profit-to-Asset %

Competitive Comparison of Hard to Treat Diseases's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Hard to Treat Diseases's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hard to Treat Diseases's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hard to Treat Diseases's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Hard to Treat Diseases's Gross-Profit-to-Asset % falls into.

Hard to Treat Diseases Gross-Profit-to-Asset % Calculation

Hard to Treat Diseases's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: . 20 )	/	( (Total Assets (A: . 20 )	+	Total Assets (A: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

Hard to Treat Diseases's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: . 20 )	/	( (Total Assets (Q: . 20 )	+	Total Assets (Q: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Hard to Treat Diseases Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hard to Treat Diseases Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762

Website

http://www.htdsmedical.com

Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases Headlines

No Headlines